Researchers identify susceptibility locus for intracerebral hemorrhage

March 21, 2014 by Keith Herrell

(Medical Xpress)—Research led by a University of Cincinnati (UC) neurologist has identified and replicated a genomic susceptibility locus for intracerebral hemorrhage, raising the possibility of targeting a new risk factor for the most deadly subtype of stroke.

Results were published Thursday, March 20, in the American Journal of Human Genetics, a peer-reviewed scientific journal. Daniel Woo, MD, professor and vice chair of clinical research in the UC Department of Neurology and Rehabilitation Medicine and a member of the UC Neuroscience Institute, was first author of the study.

"Intracerebral hemorrhage (ICH) occurs when a blood vessel ruptures within the brain and is the subtype of stroke with the highest mortality rate," says Woo. "But in almost 40 percent of ICH cases, we don't know what caused it.

"So prevention is really of paramount importance—it's imperative that we find new in addition to the current ones, which include alcohol use and hypertension."

Woo and an international network of colleagues set out to find genetic variations that play a substantial role in risk of ICH. To accomplish that, they meta-analyzed data from six previously unpublished genome-wide association studies of ICH that enrolled subjects of European ancestry in the United States and Europe.

Finding two locations of interest from that analysis, chromosomal regions 1q22 and 12q21.1, the researchers then set out to replicate the results in an independent cohort from 19 U.S. centers that included Hispanic and African-American subjects in addition to subjects of European ancestry. They successfully replicated the results for a susceptibility locus on chromosomal region 1q22 for subjects of European and African-American ancestry, but not for Hispanics. (The susceptibility locus for 12q21.1 was not replicated.)

Woo notes that the 1q22 locus contains PMF1, a gene that codes the protein called polyamine-modulated factor 1. Polyamines are known to disrupt the blood-brain barrier and have been linked to cerebrovascular disease by several studies.

"If these results hold up, this class of proteins could be a completely new risk factor for stroke, just like hypertension or smoking," says Woo.

"Once we understand that this could be a risk factor, then we can develop numerous other investigations that could lead to identification of biological pathways that could eventually be targeted by novel therapeutic strategies."

Explore further: Study sheds light on genetic factors for intracranial aneurysm

Related Stories

Study sheds light on genetic factors for intracranial aneurysm

February 14, 2014

(Medical Xpress)—A large collaborative study that included researchers from the University of Cincinnati (UC) College of Medicine is reporting a new chromosomal region associated with intracranial aneurysm susceptibility, ...

Infant, child stroke survivors prone to seizures, epilepsy

February 7, 2013

About one-third of American infants and children who suffer bleeding into brain tissue, may later have seizures and as many as 13 percent will develop epilepsy within two years, according to new research reported at the American ...

Antiplatelet drugs don't up ICH risk in new study

March 25, 2013

(HealthDay)—Pre-existing antiplatelet use does not seem to be associated with an increased risk of ischemic hemorrhage (ICH), according to an observational study published in the February issue of Academic Emergency Medicine.

Recommended for you

Epigenetic factors linked to obesity-related disease

January 17, 2017

Obesity has been linked to "letter" changes at many different sites in the genome, yet these differences do not fully explain the variation in people's body mass index (BMI) or why some overweight people develop health complications ...

Are you ready to explore baby's genome?

January 17, 2017

When you have a baby, a nurse or a phlebotomist performs a heel stick to take a few drops of blood from your infant and sends it off to a state lab for a battery of tests. Most of the time, you never hear about the results ...

Study applies game theory to genomic privacy

January 17, 2017

It comes down to privacy—biomedical research can't proceed without human genomic data sharing, and genomic data sharing can't proceed without some reasonable level of assurance that de-identified data from patients and ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.